Frontiers in Pharmacology | Pharmacoepidemiology

Systematic Review

Published on 02 Jul 2025

Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

in Pharmacoepidemiology

Peipei Li
Weiwei Chen
Rui Chen
Hanmo Zhang
Zhixi Yu
Hongyu Yan
Beibei Du
Ping Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558367

2,758 views
1 citation

Original Research

Published on 02 Jul 2025

Antidepressant use in the Canary Islands (Spain): a retrospective study of provincial, island and municipal trends and associated factors

in Pharmacoepidemiology

Alexis Oliva
Vanessa Moreno
Mariana Sapino
Sandra Dévora
Susana Abdala-Kuri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511936

1,691 views

Original Research

Published on 01 Jul 2025

Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension

in Pharmacoepidemiology

Huan Yu
Zhike Liu
Yiqun Wu
Liuyan Zheng
Kun Wang
Jingxian Wu
Huairong Wang
Kexin Ding
Ruotong Yang
Huziwei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559604

2,306 views
1 citation

Original Research

Published on 30 Jun 2025

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

in Pharmacoepidemiology

Xiang Li
Si-Qi Zhang
Ke-Rui Wang
Shi-Nan Wu
Meng-Yuan Wang
Cui-Ting Chen
Nuo Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498814

3,465 views
1 citation

Original Research

Published on 30 Jun 2025

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data

in Pharmacoepidemiology

Yani Hu
Pu Miao
Shunan Chen
Fengqian Mao
Suhong Wang
Jianhua Feng
Jie Chen
Lingyan Yu
Haibin Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549069

1,674 views
1 citation

Original Research

Published on 27 Jun 2025

Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021

in Pharmacoepidemiology

Lin Yin
Shuzhi Lin
Qian Liu
Xiaoying Zhu
Wei Liu
Yifang Shen
Zimeng Li
Bianling Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592957

1,458 views

Original Research

Published on 26 Jun 2025

Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system

in Pharmacoepidemiology

Jinfeng Liu
Junyi Tan
Qinli Xiao
Yingtao Bai
En Chang
Chun Su
Yuxun Wei
Hu Zhong
Wei Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532461

2,839 views
1 citation

Original Research

Published on 23 Jun 2025

Adverse drug reaction signal detection via the long short-term memory model

in Pharmacoepidemiology

Mengqi Cao
Yanna Chi
Jinyang Yu
Yu Yang
Ruogu Meng
Jinzhu Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554650

2,317 views
1 citation

Original Research

Published on 20 Jun 2025

Application and evaluation of the global trigger tool approach to adverse drug event monitoring in the high-risk elderly inpatients with multiple chronic diseases

in Pharmacoepidemiology

Na Li
Xiao-Min Lv
Chen-Yang Jiao
Dong-Li Zhang
Lin-Wei Chen
Yi-Ling Chang
Jin-Fang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594176

1,475 views

Original Research

Published on 18 Jun 2025

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records

in Pharmacoepidemiology

Zhizhou Wang
Ke Wang
Yiming Hua
Xin Hu
Xiaotong Zhang
Xiaoxi Li
Xiaoxuan Xing
Yingnan Feng
Chao Wu
Zhichao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528633

1,510 views

Original Research

Published on 18 Jun 2025

What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?

in Pharmacoepidemiology

Qing Shan
Lei Wang
Xia Liu
Yan Chen
Bing Li
Yuhang Guo
Qiang Fu
Jinmin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477127

2,618 views

Original Research

Published on 12 Jun 2025

Heart failure medication treatment and prognosis: a retrospective cross-sectional study

in Pharmacoepidemiology

Qiankai Lin
Zongjie Lv
Daiyi Li
Qiao Ling
Sha Qiu
Xiaomei Lei
Fang Qin
Na Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532123

3,733 views

Original Research

Published on 11 Jun 2025

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study

in Pharmacoepidemiology

Ana Rita Fortunato
Cátia Barbosa
Ariana Araujo
Fernando Fernandez-Llimos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1605458

1,901 views

Original Research

Published on 10 Jun 2025

Exploring multidimensional determinants of medication error reporting in China: a qualitative study using the theoretical domains framework

in Pharmacoepidemiology

Hui Guo
Qian Guo
Xiuping Wang
Yonghong Liu
Ze Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590794

2,367 views

Original Research

Published on 09 Jun 2025

Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

in Pharmacoepidemiology

Siyu Lou
Huayou Chen
Zhiwei Cui
Xiyuan Zhang
Chengyu Zhu
Linmei Zhou
Yingyong Ou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516449

4,961 views
3 citations

Original Research

Published on 30 May 2025

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery

in Pharmacoepidemiology

Zichao Ji
Xin Wang
Jiawei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1553221

2,104 views
1 citation

Original Research

Published on 30 May 2025

Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system

in Pharmacoepidemiology

Wensheng Liu
Feifei Gao
Xue Song
Hao Chen
Youjun She
Jiyong Liu
Qiong Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558128

4,832 views
3 citations

Original Research

Published on 26 May 2025

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system

in Pharmacoepidemiology

Haolin Teng
Shengnan Zhang
Jinyu Yu
Faping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1518258

2,819 views
2 citations

Original Research

Published on 22 May 2025

Prevalence and factors associated with Chinese herbal medicine use among middle-aged and older Chinese adults with diabetes mellitus

in Pharmacoepidemiology

Yanting Chen
Leying Lin
Shanwei Sun
Kaiwang Cui
Qingrong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1482228

2,719 views

Systematic Review

Published on 22 May 2025

A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations

in Pharmacoepidemiology

Pierluigi Navarra
Luca Buzzonetti
Valentina Amico
Melina Cro
Bruno Federico

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497667

5,235 views

Original Research

Published on 22 May 2025

Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin

in Pharmacoepidemiology

Pei Zhang
Qiong Chen
Jiahui Lao
Juan Shi
Jia Cao
Xiao Li
Xin Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538074

2,255 views
6 citations

Original Research

Published on 21 May 2025

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

in Pharmacoepidemiology

Anaelle Weissgerber
Maren Hermanns-Clausen
Evelyn Lamy

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571025

3,992 views

Original Research

Published on 20 May 2025

Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

in Pharmacoepidemiology

Rafael Nogueira de Souza
Marília Berlofa Visacri
Fabiana Bragança Albanese Trotta
Deise de Souza Ventura
Mauricio Wesley Perroud
Patrícia Moriel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514942

2,191 views

Original Research

Published on 20 May 2025

Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons’ Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan

in Pharmacoepidemiology

Halima Sadia
Safila Naveed
Hina Rehman
Shazia Jamshed
Huma Dilshad

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551819

2,666 views

571 articles

articles

Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

Antidepressant use in the Canary Islands (Spain): a retrospective study of provincial, island and municipal trends and associated factors

Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data

Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021

Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system

Adverse drug reaction signal detection via the long short-term memory model

Application and evaluation of the global trigger tool approach to adverse drug event monitoring in the high-risk elderly inpatients with multiple chronic diseases

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records

What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?

Heart failure medication treatment and prognosis: a retrospective cross-sectional study

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study

Exploring multidimensional determinants of medication error reporting in China: a qualitative study using the theoretical domains framework

Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery

Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system

Prevalence and factors associated with Chinese herbal medicine use among middle-aged and older Chinese adults with diabetes mellitus

A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations

Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons’ Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan